Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)

CNY 4.19

(-0.48%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 9.24 Billion 9.79 Billion 9.62 Billion 9.66 Billion 10.41 Billion 10.85 Billion
Total Current Assets 5.41 Billion 5.8 Billion 5.57 Billion 6.09 Billion 6.17 Billion 6.67 Billion
Cash And Short Term Investments 805.98 Million 899.18 Million 624.64 Million 1.77 Billion 1.23 Billion 1.61 Billion
Cash and Cash Equivalents 805.98 Million 899.18 Million 624.64 Million 1.77 Billion 1.23 Billion 1.61 Billion
Short Term Investments - - 0.89 0.31 0.96 -132.24 Million
Net Receivables 3.36 Billion 3.87 Billion 4.01 Billion 3.46 Billion 3.93 Billion 3.99 Billion
Inventory 1 Billion 1.03 Billion 935.7 Million 843.39 Million 994.31 Million 1.04 Billion
Other Current Assets 243.63 Million 3.65 Million 4.69 Million 4.61 Million 12.62 Million 17.93 Million
Total Non-Current Assets 3.83 Billion 3.98 Billion 4.05 Billion 3.57 Billion 4.24 Billion 4.18 Billion
Net PPE 2.51 Billion 2.67 Billion 2.7 Billion 2.32 Billion 2.75 Billion 2.77 Billion
Good Will And Intangible Assets 783.92 Million 811.71 Million 824.99 Million 825.09 Million 1.08 Billion 1.1 Billion
Good Will 603.74 Million 607.34 Million 607.34 Million 605.53 Million 778.21 Million 778.21 Million
Intangible Assets 180.17 Million 204.37 Million 217.64 Million 219.55 Million 307.78 Million 328.04 Million
Long-Term Investments 375.47 Million 343.83 Million 347.41 Million 223.03 Million 146.34 Million 220.69 Million
Tax Assets 74.13 Million 62.39 Million 55.61 Million 46.5 Million 52.91 Million 43.33 Million
Other Non Current Assets 81.84 Million 97.21 Million 118.36 Million 153.18 Million 208.16 Million 36 Million
Other Assets 1.00 - - 1.00 - 1.00
Total Liabilities 2.08 Billion 2.72 Billion 2.8 Billion 4.49 Billion 5.37 Billion 5.68 Billion
Total Current Liabilities 2.05 Billion 2.68 Billion 2.75 Billion 4.47 Billion 5 Billion 5.33 Billion
Account Payables 654.63 Million 977.23 Million 993.43 Million 788.57 Million 1.02 Billion 1.06 Billion
Tax Payables 21.08 Million 33.28 Million 37.38 Million 32.15 Million 44.05 Million 35.9 Million
Short Term Debt 1.06 Billion 1.34 Billion 1.36 Billion 3.38 Billion 3.46 Billion 3.87 Billion
Deferred Revenue 27.98 Million 33.23 Million 392.36 Million 294.8 Million 428.61 Million 35.9 Million
Other Current Liabilities 313.17 Million 330.58 Million 6.53 Million 4.56 Million 99.56 Million 364.79 Million
Total Non Current Liabilities 22.27 Million 41.23 Million 45.52 Million 23.22 Million 361.61 Million 348.5 Million
Long-Term Debt 21.12 Million 22.02 Million 24.81 Million 24.54 Million 298.63 Million 323.18 Million
Deferred Revenue Non Current 22.03 Million 18.88 Million 20.37 Million 22.87 Million 62.62 Million 24.94 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -21.73 Million -237.57 Thousand 337.9 Thousand 352.9 Thousand 352.9 Thousand 371.9 Thousand
Other Liabilities 1.00 1.00 1.00 1.00 1.00 -
Total Equity 7.14 Billion 7.06 Billion 6.82 Billion 5.16 Billion 5.04 Billion 5.16 Billion
Stock Holders Equity 6.85 Billion 6.8 Billion 6.61 Billion 4.91 Billion 4.83 Billion 4.96 Billion
Common Stock 1.94 Billion 1.94 Billion 2.02 Billion 1.66 Billion 1.66 Billion 1.66 Billion
Retained Earnings 532.31 Million 373.21 Million 271.5 Million 27.95 Million -126.7 Million -363 Million
Accumulated other comprehensive income 201.04 Million 189.64 Million 102.66 Million 57.26 Million 63.34 Million 41.95 Million
Common Stock Equity 6.85 Billion 6.8 Billion 6.61 Billion 4.91 Billion 4.83 Billion 4.96 Billion
Capital Lease Obligation 21.12 Million 22.02 Million 24.81 Million 24.54 Million - -
Total Investments 375.47 Million 343.83 Million 347.41 Million 223.03 Million 146.34 Million 88.44 Million
Total Debt 1.08 Billion 1.36 Billion 1.38 Billion 3.38 Billion 3.75 Billion 4.19 Billion
Net Debt 277.92 Million 468.59 Million 762.45 Million 1.6 Billion 2.52 Billion 2.58 Billion

Balance Sheet Charts